ECOR News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

EC

Mkt Cap

$70.9M

Volume

138.16K

Next Earnings

November 4th

Loading chart

EC

ECORelectroCore, Inc. Common Stock

ECOR

Pay with—

Available Balance0.00

EC

Mkt Cap

$75.3M

Volume

138.16K

Next Earnings

November 4th

Chart Financials Earnings News About Insider Filings

electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?electroCore (ECOR) shares surged 6.9% to $11.38 following raised 2026 revenue-growth outlook of over 30% and improved operating performance. Q2 revenues increased 28% YoY to $9.5 million with narrowed adjusted EBITDA losses. However, the stock carries a Zacks Rank #3 (Hold) as earnings estimate revisions have remained flat over the past 30 days.Zacks Investment Research · Sep 18, 2026

electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle AwardselectroCore announced that its Truvaga non-invasive vagus nerve stimulation (nVNS) wellness brand has been named the 2026 Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards. The recognition highlights Truvaga's combination of patented technology, thoughtful design, and personalized customer experience. The company also reported Q2 2026 net sales of $9.5 million, a 28% increase year-over-year, with net losses decreasing 17%.GlobeNewswire Inc. · Aug 25, 2026

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClubelectroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine company, announced it will present at Planet MicroCap Las Vegas 2026 on June 17-18 at the Bellagio Resort & Casino. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings to discuss the company's strategy and growth opportunities.GlobeNewswire Inc. · Jun 2, 2026

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026electroCore, Inc. (Nasdaq: ECOR) announced its participation in the LD Micro Invitational XVI Conference on May 18, 2026, in Los Angeles. Interim President and CFO Joshua Lev will present and conduct one-on-one meetings. The company reported Q1 2026 net sales of $9.6 million, up 43% year-over-year, though it posted a net loss of $5.3 million with improved Adjusted EBITDA.GlobeNewswire Inc. · May 9, 2026

electroCore to Present at the Market Movers Investor Summit on May 5, 2026electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine company, announced its participation in the Market Movers Investor Summit on May 5, 2026, at the Bank of New York in New York City. Joshua Lev, Interim President and CFO, will deliver a presentation and conduct one-on-one investor meetings.GlobeNewswire Inc. · Apr 28, 2026

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSDelectroCore published clinical findings in Frontiers in Neuroscience demonstrating that adjunctive non-invasive vagus nerve stimulation (nVNS) significantly reduced symptom burden in 35 patients with chronic mild traumatic brain injury and comorbid PTSD, showing improvements across cognitive, affective, and somatic domains.GlobeNewswire Inc. · Apr 1, 2026

Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)electroCore announced a new research initiative with Acacia Clinics and the Vagus Nerve Society to study gammaCore Sapphire, a non-invasive vagus nerve stimulator, as an adjunctive treatment for PTSD symptoms. The 10-month study will enroll up to 40 subjects aged 18-70 and measure safety and efficacy using clinical assessment scales. electroCore is providing an educational grant and devices for the research.GlobeNewswire Inc. · Jan 21, 2026

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the BoardelectroCore announced Peter Cuneo's departure from the Board of Directors and elected Thomas J. Errico, MD as the new Chairman, effective September 2, 2025. Cuneo will continue as a strategic advisor to the company.GlobeNewswire Inc. · Sep 5, 2025

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic TechnologieselectroCore, Inc. has completed the acquisition of NeuroMetrix, Inc., gaining access to the Quell platform and positioning itself as a leader in non-invasive bioelectronic technologies for chronic pain and wellness markets.GlobeNewswire Inc. · May 2, 2025

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain InjuriesA study presented at the 2025 International Brain Injury Association World Congress found that the use of gammaCore non-invasive vagus nerve stimulation (nVNS) significantly improved concussive symptoms in patients with mild traumatic brain injury, regardless of the time since injury.GlobeNewswire Inc. · Apr 17, 2025

to start trading

EC

ECORelectroCore, Inc. Common Stock

ECOR

Pay with—

Available Balance0.00

Your PositionYou don't own any ECOR yet.

Related Tickers

Earnings